title: Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
abstract: Chronic kidney disease (CKD) is a worldwide public health problem, with adverse outcomes of kidney failure, cardiovascular disease (CVD), and premature death. A simple definition and classification of kidney disease is necessary for international development and implementation of clinical practice guidelines. Kidney Disease: Improving Global Outcomes (KDIGO) conducted a survey and sponsored a controversies conference to (1) provide a clear understanding to both the nephrology and nonnephrology communities of the evidence base for the definition and classification recommended by Kidney Disease Quality Outcome Initiative (K/DOQI), (2) develop global consensus for the adoption of a simple definition and classification system, and (3) identify a collaborative research agenda and plan that would improve the evidence base and facilitate implementation of the definition and classification of CKD. The K/DOQI definition and classification were accepted, with clarifications. CKD is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m(2) for 3 months or more, irrespective of cause. Kidney damage in many kidney diseases can be ascertained by the presence of albuminuria, defined as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens. GFR can be estimated from calibrated serum creatinine and estimating equations, such as the Modification of Diet in Renal Disease (MDRD) Study equation or the Cockcroft-Gault formula. Kidney disease severity is classified into five stages according to the level of GFR. Kidney disease treatment by dialysis and transplantation should be noted. Simple, uniform classifications of CKD by cause and by risks for kidney disease progression and CVD should be developed.
authors.affiliation: Tufts-New England Medical Center, Boston, Massachusetts 02111, USA. alevey@tufts-nemc.org
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Levey
authors.forename: Kai-Uwe
authors.initials: KU
authors.lastname: Eckardt
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Tsukamoto
authors.forename: Adeera
authors.initials: A
authors.lastname: Levin
authors.forename: Josef
authors.initials: J
authors.lastname: Coresh
authors.forename: Jerome
authors.initials: J
authors.lastname: Rossert
authors.forename: Dick
authors.initials: D
authors.lastname: De Zeeuw
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Hostetter
authors.forename: Norbert
authors.initials: N
authors.lastname: Lameire
authors.forename: Garabed
authors.initials: G
authors.lastname: Eknoyan
mesh_terms: D000419:Albuminuria / Q000209:etiology; D002908:Chronic Disease; D005919:Glomerular Filtration Rate; D006801:Humans; D007674:Kidney Diseases / Q000145:classification* / Q000209:etiology; D011507:Proteinuria / Q000209:etiology; D012307:Risk Factors